TROP2 ADC | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,561 results for “TROP2 ADC”

Trials

View all 3360 →

Active, not recruiting

Different Targeted Antibody-drug Conjugates For HER2 Ultra-low or No Expression Advanced Breast Cancer（GALAXY）

56 participants · First posted Apr 21, 2023

PET/CT for Trop2 ADC Response Evaluation NSCLC

50 participants · First posted Sep 3, 2025

PET/CT for Trop2 ADC Response Evaluation Cancers

50 participants · First posted Jul 1, 2025

Drugs

View all 778 →

Trop2-adc

TROP2 ADC(luzsana)

Biparatopic trop2-ADC(RemeGen )

Organizations

View all 68 →

ADC Therapeutics

Switzerland

ADC Therapeutics America, Inc.

United States

Lophora ApS

Denmark

News

View all 1355 →

TROP2-Directed Therapies Show Promise in Breast and Lung Cancers

Cancer Research UK and KisoJi Biotechnology Collaborate to Advance Novel Anti-TROP2 Antibody KJ-103 into Clinical Trials

Cancer Research UK and KisoJi Biotech Partner to Advance Novel Anti-TROP2 Antibody KJ-103

Page 1 of 557